Topiramate Capsule, Coated Pellets
Product Images NDC 68462-218

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68462-218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a line graph showing cumulative rates for time to first seizure over 500 days for Topiramate at 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative seizure rates. The graph compares two patient groups with sample sizes noted, including a p-value of 0.0002 indicating statistical analysis.*

FDA Label Image

Figure2 (Figure2)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate (±SE) across four groups: Placebo, Topiramate 50 mg/day, 100 mg/day, and 200 mg/day. Data from two studies (Study 11 and Study 12) are shown for each group. Significance levels for comparisons are indicated with asterisks (* for p < 0.010, ** for p < 0.001). Sample sizes per group are provided at the top.*

FDA Label Image

Structure (Image 01)

Chemical structure of topiramate, the active ingredient shown by its molecular formula illustration with labeled atoms and bonds representing its chemical composition.*

FDA Label Image

Label15mg (Label15mg)

Topiramate Capsules, USP 15 mg, oral coated pellets in a capsule container. The label shows a 60 capsule count, marked Rx only, from Glenmark Pharmaceuticals Inc., USA. Instructions advise pharmacists to dispense the Medication Guide to patients. The label includes storage, dosage, and safety information.*

FDA Label Image

Label25mg (Label25mg)

Label for Topiramate Capsules, USP 25 mg by Glenmark Pharmaceuticals Inc. The label states 60 capsules per container, with capsules described as white to off-white spherical pellets in a white opaque capsule. The label includes handling instructions, storage conditions, and manufacturer details indicating the product is made in India for Glenmark Pharmaceuticals USA.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo2 (Logo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.